Advertisement
Person › Details
Manuel Litchman (Mustang Bio Inc. (Nasdaq: MBIO))
Litchman, Manuel (Mustang Bio 201704– CEO before Arvinas + Novartis Pharmaceuticals Corp)
Organisation | Mustang Bio Inc. (Nasdaq: MBIO) | |
Former/major organisation | Arvinas Inc. (Nasdaq: ARVN) | |
Group | Arvinas (Group) | |
Product | gene therapy | |
Product 2 | PROTAC technology (proteolysis targeting chimeric molecules) | |
Record changed: 2020-11-07 |
Advertisement
More documents for Manuel Litchman
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top